Strategy of Targeted T Cell Immunotherapy for Acute Myeloid Leukemia
T cell dysfunction is a common feature in patients with acute myeloid leukemia (AML). The up-regulation of immune checkpoint (IC) proteins resulting in T cell exhaustion is a key reason for T cell dysfunction. Immunotherapy with IC inhibitors exerts a remarkable effect on AML. However, due to the he...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Artigo |
| Reo: | Chinês |
| I whakaputaina: |
Magazine House of Cancer Research on Prevention and Treatment
2024-04-01
|
| Rangatū: | Zhongliu Fangzhi Yanjiu |
| Ngā marau: | |
| Urunga tuihono: | http://www.zlfzyj.com/en/article/doi/10.3971/j.issn.1000-8578.2024.24.0016 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|